Latest Research for August

It’s been a busy month already for Aussie DFD research, and at DFA 2023 we’re excited to release our line up of oral abstract speakers in our updated conference program and more details about our special Charcot Masterclass.  We’re also hosting a special pre-conference mini symposium  (Sunday 3-5pm) where we’re inviting multi-disciplinary health professionals, researchers and organisations to discuss: where national DFD research is at currently, lessons and learnings from our international experts on collaborative research programs, what’s needed next and how to get involved. In this interactive session, we want to hear from you. As we work towards bringing the DFD community together to conduct research that makes a real difference and supports new innovations in clinical care delivery. So head to the conference webpage to learn more – limited registrations open soon!

Recent developments in targets for ischemic foot disease.

Golledge J, Thanigaimani S, Barratt KS, Fadini GP.
Diabetes Metab Res Rev. 2023 Aug 10:e3703. doi: 10.1002/dmrr.3703. Online ahead of print.
PMID: 37563926 Review

The experiences of health workers using telehealth services for diabetes-related foot complications: a qualitative exploration.

Graham K, Siatis CM, Gunn KM, Ong E, Loughry C, McMillan N, Fitridge R.
J Foot Ankle Res. 2023 Aug 9;16(1):47. doi: 10.1186/s13047-023-00645-9.
PMID: 37553572 Free PMC article.

Neuropeptide substance P: A promising regulator of wound healing in diabetic foot ulcers.

Chen J, Ye P, Gu R, Zhu H, He W, Mu X, Wu X, Pang H, Han F, Nie X.
Biochem Pharmacol. 2023 Aug 5;215:115736. doi: 10.1016/j.bcp.2023.115736. Online ahead of print.
PMID: 37549795 Review

Cohort Study Examining the Presentation, Distribution, and Outcomes of Peripheral Artery Disease in Aboriginal, Torres Strait Islander, and Non-Indigenous Australians.

Alahakoon C, Singh TP, Morris D, Charles J, Fernando M, Lazzarini P, Moxon JV, Golledge J.
Eur J Vasc Endovasc Surg. 2023 Aug;66(2):237-244. doi: 10.1016/j.ejvs.2023.05.027. Epub 2023 May 18.
PMID: 37209994

Risk Factors for Hospital Re-admission for Diabetes Related Foot Disease: A Prospective Cohort Study.

Alahakoon C, Singh TP, Galappaththy C, Charles J, Fernando M, Lazzarini P, Moxon JV, Golledge J.
Eur J Vasc Endovasc Surg. 2023 Aug;66(2):221-228. doi: 10.1016/j.ejvs.2023.05.016. Epub 2023 May 16.
PMID: 37196911

Detection, management, and prevention of diabetes-related foot disease in the Australian context.

McNeil S, Waller K, Poy Lorenzo YS, Mateevici OC, Telianidis S, Qi S, Churilov I, MacIsaac RJ, Galligan A.
World J Diabetes. 2023 Jul 15;14(7):942-957. doi: 10.4239/wjd.v14.i7.942.
PMID: 37547594 Free PMC article. Review.

Effectiveness of revascularisation for the ulcerated foot in patients with diabetes and peripheral artery disease: A systematic review.

Chuter V, Schaper N, Mills J, Hinchliffe R, Russell D, Azuma N, Behrendt CA, Boyko EJ, Conte MS, Humphries MD, Kirksey L, McGinigle KC, Nikol S, Nordanstig J, Rowe V, van den Berg JC, Venermo M, Fitridge R.
Diabetes Metab Res Rev. 2023 Aug 4:e3700. doi: 10.1002/dmrr.3700. Online ahead of print.
PMID: 37539634

Diabetic Retinopathy Screening at the Point of Care (DR SPOC): detecting undiagnosed and vision-threatening retinopathy by integrating portable technologies within existing services.

Weerasinghe LS, Dunn HP, Fung AT, Maberly G, Cheung NW, Weerasinghe DP, Liew G, Do H, Hng TM, Pryke A, Marks SI, Nguyen H, Jayaballa R, Gurung S, Ford B, Bishay RH, Girgis CM, Meyerowitz-Katz G, Keay L, White AJ.
BMJ Open Diabetes Res Care. 2023 Aug;11(4):e003376. doi: 10.1136/bmjdrc-2023-003376.
PMID: 37532459 Free PMC article.

Mönckeberg’s Medial Calcific Sclerosis Makes Traditional Arterial Doppler’s Unreliable in High-Risk Patients with Diabetes.

Suludere MA, Danesh SK, Killeen AL, Crisologo PA, Malone M, Siah MC, Lavery LA.
Int J Low Extrem Wounds. 2023 Jul 31:15347346231191588. doi: 10.1177/15347346231191588. Online ahead of print.
PMID: 37525549

We’re only 7 weeks away from the DFA Conference – it’s time to get those skates on! The International Working Group on the Diabetic Foot (IWGDF) has published evidence-based guidelines on the prevention and management of diabetic foot disease since 1999. And the just released 2023 IWGDF Guidelines, includes the first guideline on the diagnosis and treatment of active Charcot Neuro-osteoarthropathy in persons with diabetes published by the IWGDF.  We are so very lucky to have both the chair and the secretary from the 2023 IWGDF Charcot Guideline joining us at DFA2023 where you can learn the latest in person at our special Charcot Masterclass offered on both Monday 09 Oct and Tues 10 Oct. Learn more and register